EdgarLookup

Zentalis Pharmaceuticals, Inc.

ZNTL NASDAQ CIK: 0001725160 Pharmaceutical Preparations
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 516 filings →
Form Description Date
10-K 10-K Mar 26, 2026
8-K 8-K Mar 26, 2026
SCHEDULE 13G Mar 3, 2026
4 FORM 4 Feb 10, 2026
4 FORM 4 Feb 10, 2026
4 FORM 4 Feb 10, 2026
4 FORM 4 Feb 4, 2026
4 FORM 4 Jan 9, 2026
4 FORM 4 Jan 9, 2026
4 FORM 4 Jan 9, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
GOEL DAVID E. Sale 7,500,000 @ $1.33 6,459,973 Dec 15, 2025
Walker Luke Nathaniel Award / Grant 57,603 144,284 Jun 17, 2025
Skvarka Jan Award / Grant 57,603 207,154 Jun 17, 2025
Johnson David Michael Award / Grant 57,603 250,421 Jun 17, 2025
Kariuki Enoch Award / Grant 57,603 137,365 Jun 17, 2025
Myers Scott Dunseth Award / Grant 57,603 338,795 Jun 17, 2025
Myers Scott Dunseth Purchase 21,000 @ $1.40 281,192 Apr 30, 2025
Bruns Ingmar Chief Medical Officer Purchase 20,000 @ $2.28 36,629 Feb 6, 2025
Vultaggio Vincent PAO and Interim PFO Sale 2,615 @ $1.71 189,826 Feb 3, 2025
Lackner Mark Chief Scientific Officer Sale 14,368 @ $1.71 512,856 Feb 3, 2025